US 11813319
Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 11813319 (Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/5254, A61K39/12, A61P, A61P31/20